Islet Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-50,000
Closed -$4.57M 94
2019
Q2
$4.57M Sell
50,000
-89,500
-64% -$7.57M 0.52% 55
2019
Q1
$12M Buy
139,500
+55,800
+67% +$4.48M 1.39% 19
2018
Q4
$6.44M Buy
+83,700
New +$6.52M 1.03% 25

Other funds holding NVS

Islet Management's NVS Position: Q3 2019 in Review

Islet Management sold out of Novartis (NVS) in Q3 2019, closing a stake of 50,000 shares — an estimated $4.57M sold.

Islet Management first reported a position in NVS in Q4 2018 and held it in 3 quarters. The position peaked at $12M in Q1 2019. 1,090 funds tracked by Wall St. Rank hold NVS as of Q3 2019.

  • Islet Management reported no remaining Novartis position as of Q3 2019 after selling out during the quarter.
  • Islet Management sold 50,000 Novartis shares in Q3 2019, an estimated $4.57M.
  • Islet Management first reported a position in Novartis in Q4 2018 and held it in 3 quarters.
  • Islet Management's Novartis position peaked at $12M in Q1 2019.
  • 1,090 funds tracked by Wall St. Rank held Novartis as of Q3 2019.

Based on Islet Management's 13F filing for Q3 2019, filed 14 Nov 2019.